Ambulanc (Shenzhen) Tech. Co., Ltd was established in 2001 by a group of experts in emergency care. Our brand Amoul® is dedicated to innovation and the development of comprehensive life support solutions, and manufacturing respiratory therapy, cardiopulmonary resuscitation (CPR), anesthesia, emergency care, and critical care devices.
The professional R&D team plays a pivotal role in advancing technologies for pneumatic and turbine life support ventilation, CPR, airway management, conscious sedation devices, and anesthesia machines, serving healthcare professionals and patients globally.
Ambulanc owns 1000+ patents and CFDA medical device registration certificates for Class II and Class III medical equipment, besides a wide range of international certifications such as ISO13485, FDA (EUA), CE, MDL, TAG, etc. Our products are distributed across 100+ countries and regions worldwide.
-
2001SINCE
-
700+EMPLOYEES
-
20000+VALUED CUSTOMERS
-
03Amoul® Showcases the Future of Critical Care at WHX 2026 JohannesburgThe emergency and critical care field is rapidly evolving, driven by technological advancements. This October, Johannesburg will host WHX 2026, where Amoul® will showcase groundbreaking innovations like advanced ventilatory support and automated resuscitation devices. Don't miss this key event for healthcare professionals passionate about the future of patient care.news More
English
中文
Pусский
Español
عربى
Français
Português
Deutsch






